Hello everyone,
I am just finishing up my last rounds of my second line of treatment (Carbo Caelyx). I am Stage 3 HGSOC diagnosed in July 2024. My team in Montreal has just informed me that I am possibly eligible for a new clinical study using an ADC sacituzumab tirumotecan (Sac-TMT) as a maintenance drug for platinum sensitive cancer rather then waiting and using later for platinum resistant. It is a phase 3 trial and either you are in the treatment group or a watch and wait control group. There is no "name" for this trial that I am aware of…only the number. I have heard of other ADCs but not this one. Has anyone got any experience with itt? I was not expecting the option to go back into treatment so soon after finishing this last round of chemo. I am on the fence but leaning towards participating. Just looking to see if anyone has any experience with this drug, good or bad. Thank you!
-------------------------------------------